Music intensifies effects of anti-hypertensive medication
- Details
- Category: Research
In addition to remembering to take the medication prescribed by their cardiologists at the right times and going to the trouble of making healthy lifestyle changes, patients with high blood pressure (hypertension) can include a pleasing beneficial activity in routine treatment of the disease thanks to the discovery that listening to music significantly enhances the effect of anti-hypertensive drugs.
Diabetes drug may not reduce risk of death
- Details
- Category: Research
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. The research, led by scientists from Imperial College London and published in the Journal of the American Medical Association, studied three types of diabetes treatment: sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors.
Personalized tumor vaccine shows promise in pilot trial
- Details
- Category: Research
A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania. The personalized vaccine is made from patients' own immune cells, which are exposed in the laboratory to the contents of the patients' tumor cells, and then injected into the patients to initiate a wider immune response.
New class of drugs could help tackle treatment-resistant cancers
- Details
- Category: Research
Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies. The drug may not become available to patients for a number of years yet, but researchers believe that if clinical trials are successful, it could be used to tackle a variety of treatment-resistant cancers.
New immunotherapy for lung cancer shows promise of success
- Details
- Category: Research
In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease's progression. The study, published April 4 in the journal The Lancet Oncology, focused on non-small cell lung cancer, which is the most common form of lung cancer.
Human drug trials are compromised by poor reporting of animal research
- Details
- Category: Research
Poor animal study design and reporting thwarts the ethical review of proposed human drug trials, according to a study led by researchers at Hannover Medical School, Germany, in cooperation with researchers from McGill University, Canada. The study, publishing 5 April in the open access journal PLOS Biology, analyzed the descriptions of animal studies found in "investigator brochures" -
'Coffee filter' helps make new cancer drug Z-endoxifen 1,000 times cheaper
- Details
- Category: Research
Making drugs cheaper doesn't always require pricey investments. A joint initiative by researchers from Eindhoven University of Technology (TU/e), the Dutch company Syncom BV and the Antoni van Leeuwenhoek hospital proves just that. What started out as a Bachelor project at TU/e laid the foundation for a much cheaper production of the promising cancer drug Z-endoxifen.
More Pharma News ...
- Researchers propose key elements of antimicrobial stewardship for hospitals worldwide
- When drugs are wrong, skipped or make you sick: The cost of non-optimized medications
- Researchers identify chemical compound that inhibits Ebola virus replication
- Taking a standard prostate cancer drug with food boosts impact, lowers cost
- Canadian neuroscientists say daily ibuprofen can prevent Alzheimer's disease
- New targeted therapy schedule could keep melanoma at bay
- First proof a synthesized antibiotic is capable of treating superbugs